Author
Listed:
- Jonas Fuchs
(University of Freiburg)
- Vivien Karl
(University of Freiburg
University of Freiburg)
- Ina Hettich
(University of Freiburg)
- Jaime Alvarado
(University of Freiburg)
- Daniel Eckert
(University of Freiburg)
- Lena Jaki
(University of Freiburg)
- Ann-Kathrin Kohl
(University of Freiburg)
- Anastasia Kremser
(University of Freiburg
University of Freiburg)
- Anastasija Maks
(University of Freiburg)
- Charlott Terschluse
(University of Freiburg
LMU Munich)
- Prerana Agarwal
(University of Freiburg)
- Florian Emmerich
(University of Freiburg)
- Sebastian Fähndrich
(University of Freiburg)
- Annabelle Flügler
(University of Freiburg)
- Daniel Hornuss
(University of Freiburg)
- Johannes Kalbhenn
(University of Freiburg)
- Nikolaus Kneidinger
(Medical University of Graz
Member of the German Center for Lung Research (DZL))
- Inga Lau
(University of Freiburg)
- Achim Lother
(University of Freiburg
University of Freiburg)
- Isabelle Moneke
(Medical Center-University of Freiburg)
- David Schibilsky
(University of Freiburg
Lucerne Cantonal Hospital)
- Elisabeth Schygulla
(University of Freiburg)
- Nils Venhoff
(University of Freiburg)
- Gernot Zissel
(University of Freiburg)
- Martin Czerny
(University of Freiburg)
- Daniela Huzly
(University of Freiburg)
- Georg Kochs
(University of Freiburg)
- Christoph Neumann-Haefelin
(University of Freiburg
University of Cologne)
- Bernward Passlick
(Medical Center-University of Freiburg)
- Daiana Stolz
(University of Freiburg)
- Robert Thimme
(University of Freiburg)
- Marcus Panning
(University of Freiburg)
- Maike Hofmann
(University of Freiburg)
- Björn C. Frye
(University of Freiburg)
Abstract
A 48-year-old patient underwent lung transplantation because of severe COVID-19, which aggravated his underlying interstitial lung disease, despite the presence of detectable SARS-CoV-2. Subsequently, the graft is re-infected early in the post-procedural phase, leading to viral persistence for more than five months. By analyzing viral evolution and effector immune response within the transplanted organ, we observe three main findings. First, virus evolution differs in the transplanted organ compared to that in the upper respiratory tract and is affected by monoclonal SARS-CoV-2-specific antibodies and molnupiravir. Second, we show the potential clinical relevance of T cell HLA restriction that may facilitate viral clearance in the upper respiratory tract compared to the ongoing viral replication in the HLA mismatch organ. Third, close monitoring and modulation of immunosuppressive and antiviral therapy enables viral clearance in a lung transplantation setting despite incomplete SARS-CoV-2 clearance prior to transplantation.
Suggested Citation
Jonas Fuchs & Vivien Karl & Ina Hettich & Jaime Alvarado & Daniel Eckert & Lena Jaki & Ann-Kathrin Kohl & Anastasia Kremser & Anastasija Maks & Charlott Terschluse & Prerana Agarwal & Florian Emmerich, 2025.
"SARS-CoV-2 infection dynamics in a MHCI-mismatched lung transplant recipient,"
Nature Communications, Nature, vol. 16(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-63681-y
DOI: 10.1038/s41467-025-63681-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-63681-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.